amgen, takeda drug fails advanced lung-cancer study
amgen inc and takeda pharmaceutical co ltd said their experimental drug, motesanib, had failed to improve overall survival in a late-stage study of patients with advanced lung cancer.
http://feeds.reuters.com/~r/reuters/healthnews/~3/sweops8f8ua/us-amgen-takeda-idustre72t2sz20110330
6069
30 Mar 2011 14:24:38
reuters
health